PERTUZUMAB ZUVOTOLIMOD

UNII:	H4LR6V1LWG
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	PERTUZUMAB ZUVOTOLIMOD
GSRS Full Record:	H4LR6V1LWG i

2500674-05-3
IMMUNOGLOBULIN G1 (DE-C-TERMINAL-LYSINE), ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR HER2) (HUMAN-MUS MUSCULUS MONOCLONAL M050 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL M050 .KAPPA.-CHAIN, DIMER, REDUCED, THIOETHER WITH N-(6-(3-MERCAPTO-2,5-DIOXO-1-PYRROLIDINYL)-1-OXOHEXYL)-L-VALYL-N5-(AMINOCARBONYL)-N-(4-((((3-(((2-AMINO-4-((DIPROPYLAMINO)CARBONYL)-3H-1-BENZAZEPIN-8-YL)CARBONYL)AMINO)-7,8-DIHYDRO-1,6-NAPHTHYRIDIN-6(5H)-YL)CARBONYL)OXY)METHYL)PHENYL)-L-ORNITHINAMIDE
SBT 6050 [WHO-DD]
pertuzumab zuvotolimod [INN]

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

PERTUZUMAB ZUVOTOLIMOD

Synonyms and Mappings

Resources